These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19517985)

  • 1. Double iterative optimisation for metabolic network-based drug target identification.
    Song B; Sridhar P; Kahveci T; Ranka S
    Int J Data Min Bioinform; 2009; 3(2):124-44. PubMed ID: 19517985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An iterative algorithm for metabolic network-based drug target identification.
    Sridhar P; Kahveci T; Ranka S
    Pac Symp Biocomput; 2007; ():88-99. PubMed ID: 17992747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.
    Guo WF; Zhang SW; Shi QQ; Zhang CM; Zeng T; Chen L
    BMC Genomics; 2018 Jan; 19(Suppl 1):924. PubMed ID: 29363426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining metabolic networks for optimal drug targets.
    Sridhar P; Song B; Kahveci T; Ranka S
    Pac Symp Biocomput; 2008; ():291-302. PubMed ID: 18229694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Boolean metabolic networks: integer linear programming based approach.
    Qiu Y; Jiang H; Ching WK; Cheng X
    BMC Syst Biol; 2018 Apr; 12(Suppl 1):7. PubMed ID: 29671395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulating the steady state of metabolic pathways.
    Song B; Büyüktahtakin IE; Ranka S; Kahveci T
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(3):732-47. PubMed ID: 20479507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.
    He C; Wu Y; Lai Y; Cai Z; Liu Y; Lai L
    Mol Biosyst; 2012 Apr; 8(5):1585-94. PubMed ID: 22446875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis.
    Singh S; Singh DB; Singh A; Gautam B; Ram G; Dwivedi S; Ramteke PW
    Interdiscip Sci; 2016 Dec; 8(4):388-394. PubMed ID: 26750924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial fatty acid metabolism in modern antibiotic discovery.
    Yao J; Rock CO
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computing Minimum Reaction Modifications in a Boolean Metabolic Network.
    Tamura T; Lu W; Song J; Akutsu T
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1853-1862. PubMed ID: 29989991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Pathway Inhibition in Liver Cancer.
    Zarrinpar A
    SLAS Technol; 2017 Jun; 22(3):237-244. PubMed ID: 28314110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Phosphoribosyl-AMP cyclohydrolase, as drug target and its inhibitors in Brucella melitensis bv. 1 16M using metabolic pathway analysis.
    Gupta M; Prasad Y; Sharma SK; Jain CK
    J Biomol Struct Dyn; 2017 Feb; 35(2):287-299. PubMed ID: 26725317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-throughput absorbance-based assay for methionine produced by methionine aminopeptidase using S-adenosyl-L-methionine synthetase.
    Shapiro AB; Gao N; Thresher J; Walkup GK; Whiteaker J
    J Biomol Screen; 2011 Jun; 16(5):494-505. PubMed ID: 21402755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.
    Erwin AL
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27235477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strategy to screen inhibitors of multiple aminoglycoside-modifying enzymes with ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
    Zhu L; Liu R; Liu T; Zou X; Xu Z; Guan H
    J Pharm Biomed Anal; 2019 Feb; 164():520-527. PubMed ID: 30458385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
    Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
    Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein interaction network analysis--approach for potential drug target identification in Mycobacterium tuberculosis.
    Kushwaha SK; Shakya M
    J Theor Biol; 2010 Jan; 262(2):284-94. PubMed ID: 19833135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.